Recent Finacing
Recent Raise
NeurAxon is a Toronto-based pharmaceutical company developing selective neuronal nitric oxide synthase (nNOS) inhibitors to modulate pain and central nervous system neuronal sensitization.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors